Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated to v3.5.4, replacing the previous v3.5.3. This indicates a software/document version update rather than a change to study content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- The page now displays a new revision number, v3.5.3, replacing the previous v3.5.2, signaling a deployment update. This update appears to be a maintenance detail rather than a substantive change to study content or user-facing information.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedSite revision updated to version v3.5.2, replacing the previous v3.5.0 entry.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No visible changes to the study details.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.2 is shown on the page header/footer. The prior government-funding operating-status notice has been removed, with no changes to the study details.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.